P2.14-34 Tyrosine-Kinase Inhibitors (TKI) in First-Line Treatment of 470 Patients with Non-Small Cell Lung Cancer (NSCLC) from the Czech Republic
2019 ◽
Vol 14
(10)
◽
pp. S842-S843
J. Skřičková
◽
P. Májková
◽
M. Bařinová
◽
M. Pešek
◽
V. Kolek
◽
...
Jana Skřičková
◽
Zdeněk Bortlíček
◽
Karel Hejduk
◽
Miloš Pešek
◽
Vítězslav Kolek
◽
...
Po‐Lan Su
◽
Chian‐Wei Chen
◽
Yi‐Lin Wu
◽
Chien‐Chung Lin
◽
Wu‐Chou Su
Joel Neal
◽
Kim-Son H. Nguyen
2014 ◽
Vol 5
◽
pp. S33-S34
M. Knetki-Wroblewska
◽
A. Pluzanski
◽
M. Krzakowski
2016 ◽
Vol 19
(7)
◽
pp. A890
KN Ku Abd Rahim
◽
HF Kamaruzaman
◽
AA Shafie
◽
S Hussain
◽
J Sabirin
2012 ◽
Vol 16
(sup2)
◽
pp. S55-S60
◽
Bruno Gori
◽
Serena Ricciardi
◽
Ester Del Signore
◽
Alberto Fulvi
◽
Filippo de Marinis
2016 ◽
Vol 19
(7)
◽
pp. A885
HF Kamaruzaman
◽
KN Ku Abd Rahim
◽
SW Lee
◽
N Mohd Darus
◽
J Sabirin
Zhonghan Zhang
◽
Yang Zhang
◽
Fan Luo
◽
Yuxiang Ma
◽
Wenfeng Fang
◽
...